Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 4—April 2022
Research

Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India

Margarita Pons-SalortComments to Author , Jacob John, Oliver J. Watson, Nicholas F. Brazeau, Robert Verity, Gagandeep Kang, and Nicholas C. Grassly
Author affiliations: Imperial College London School of Public Health, London, UK (M. Pons-Salort, O.J. Watson, N.F. Brazeau, R. Verity, N.C. Grassly); Christian Medical College, Vellore, India (J. John, G. Kang)

Main Article

Figure 4

Estimated reporting of coronavirus disease deaths, Delhi, India, March 15–September 30, 2020. Violin plots show the posterior distribution of the estimate of death reporting for 3 different values for the assumed age-adjusted IFR, using age-stratified estimates of IFR based on data from mostly high-income countries; 0.21% corresponds to lower bound, 0.39% to the median, and 0.85% to the upper bounds of the IFR based on data documented elsewhere (4). Horizontal black lines indicate the median values of the posterior distributions. IFR, infection-fatality ratio.

Figure 4. Estimated reporting of coronavirus disease deaths, Delhi, India, March 15–September 30, 2020. Violin plots show the posterior distribution of the estimate of death reporting for 3 different values for the assumed age-adjusted IFR, using age-stratified estimates of IFR based on data from mostly high-income countries; 0.21% corresponds to lower bound, 0.39% to the median, and 0.85% to the upper bounds of the IFR based on data documented elsewhere (4). Horizontal black lines indicate the median values of the posterior distributions. IFR, infection-fatality ratio.

Main Article

References
  1. Pulla  P. ‘The epidemic is growing very rapidly’: Indian government adviser fears coronavirus crisis will worsen. Nature. 2020;583:180. DOIPubMedGoogle Scholar
  2. Chatterjee  P. Is India missing COVID-19 deaths? Lancet. 2020;396:657. DOIPubMedGoogle Scholar
  3. Sharma  N, Sharma  P, Basu  S, Saxena  S, Chawla  R, Dushyant  K, et al. The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study. Trans R Soc Trop Med Hyg. 2021;•••:trab109; Epub ahead of print. DOIPubMedGoogle Scholar
  4. Brazeau  NF, Verity  R, Jenks  S, Fu  H, Whittaker  C, Winskill  P, et al. COVID-19 infection fatality ratio: estimates from seroprevalence. London: Imperial College London; 2020 [cited 2021 Mar 23]. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr
  5. O’Driscoll  M, Ribeiro Dos Santos  G, Wang  L, Cummings  DAT, Azman  AS, Paireau  J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590:140–5. DOIPubMedGoogle Scholar
  6. Verity  R, Okell  LC, Dorigatti  I, Winskill  P, Whittaker  C, Imai  N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. [Erratum in Lancet Infect Dis. 2020;20:e116.]. Lancet Infect Dis. 2020;20:669–77. DOIPubMedGoogle Scholar
  7. Levin  AT, Hanage  WP, Owusu-Boaitey  N, Cochran  KB, Walsh  SP, Meyerowitz-Katz  G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35:1123–38. DOIPubMedGoogle Scholar
  8. COVID19India [cited 2021 Mar 23]. https://www.covid19india.org
  9. Census of India. Population projections for India and states 2011–2036: report of the technical group on population projections. November 2019 [cited 2021 Mar 23]. https://nhm.gov.in/New_Updates_2018/Report_Population_Projection_2019.pdf
  10. Wallinga  J, Lipsitch  M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci. 2007;274:599–604. DOIPubMedGoogle Scholar
  11. Bi  Q, Wu  Y, Mei  S, Ye  C, Zou  X, Zhang  Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20:911–9. DOIPubMedGoogle Scholar
  12. Lau  YC, Tsang  TK, Kennedy-Shaffer  L, Kahn  R, Lau  EHY, Chen  D, et al. Joint estimation of generation time and incubation period for coronavirus disease (Covid-19). J Infect Dis. 2021;•••:jiab424; Epub ahead of print. DOIPubMedGoogle Scholar
  13. Nishiura  H, Linton  NM, Akhmetzhanov  AR. Serial interval of novel coronavirus (COVID-19) infections. Int J Infect Dis. 2020;93:284–6. DOIPubMedGoogle Scholar
  14. Xin  H, Li  Y, Wu  P, Li  Z, Lau  EHY, Qin  Y, et al. Estimating the latent period of coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;•••:ciab746. DOIPubMedGoogle Scholar
  15. Lauer  SA, Grantz  KH, Bi  Q, Jones  FK, Zheng  Q, Meredith  HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172:577–82. DOIPubMedGoogle Scholar
  16. Xin  H, Wong  JY, Murphy  C, Yeung  A, Taslim Ali  S, Wu  P, et al. The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Clin Infect Dis. 2021;73:2344–52. DOIPubMedGoogle Scholar
  17. Oran  DP, Topol  EJ. The proportion of SARS-CoV-2 infections that are asymptomatic : a systematic review. Ann Intern Med. 2021;174:655–62. DOIPubMedGoogle Scholar
  18. Beale  S, Hayward  A, Shallcross  L, Aldridge  RW, Fragaszy  E. A rapid review and meta-analysis of the asymptomatic proportion of PCR-confirmed SARS-CoV-2 infections in community settings. Wellcome Open Res. 2020;5:266. DOIGoogle Scholar
  19. Buitrago-Garcia  D, Egli-Gany  D, Counotte  MJ, Hossmann  S, Imeri  H, Ipekci  AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346. DOIPubMedGoogle Scholar
  20. Gaythorpe  K, Imai  N, Cuomo-Dannenburg  G, Baguelin  M, Bhatia  S, Boonyasiri  A, et al. Symptom progression of COVID-19. Imperial College London. 2020 [cited 2021 Mar 23]. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-8-symptom-progression-covid-19
  21. Knock  ES, Whittles  LK, Lees  JA, Perez-Guzman  PN, Verity  R, FitzJohn  RG, et al. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Sci Transl Med. 2021;13:eabg4262. DOIPubMedGoogle Scholar
  22. Salje  H, Tran Kiem  C, Lefrancq  N, Courtejoie  N, Bosetti  P, Paireau  J, et al. Estimating the burden of SARS-CoV-2 in France. [Erratum in Science. 2020;368:eabd4246]. Science. 2020;369:208–11. DOIPubMedGoogle Scholar
  23. Hay  JA. lazymcmc R package [cited 2021 Mar 23]. https://github.com/jameshay218/lazymcmc
  24. R: a language and environment for statistical computing [cited 2021 Mar 23]. https://www.gbif.org/tool/81287/r-a-language-and-environment-for-statistical-computing
  25. Malani  A, Shah  D, Kang  G, Lobo  GN, Shastri  J, Mohanan  M, et al. Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India. Lancet Glob Health. 2021;9:e110–1. DOIPubMedGoogle Scholar
  26. Laxminarayan  R, B  CM, G  VT, Arjun Kumar  KV, Wahl  B, Lewnard  JA. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study. Lancet Infect Dis. 2021;21:1665–76. DOIPubMedGoogle Scholar
  27. Clark  A, Jit  M, Warren-Gash  C, Guthrie  B, Wang  HHX, Mercer  SW, et al.; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8:e1003–17. DOIPubMedGoogle Scholar
  28. Kumar  P, Chander  B. COVID 19 mortality: Probable role of microbiome to explain disparity. Med Hypotheses. 2020;144:110209. DOIPubMedGoogle Scholar
  29. Walker  PGT, Whittaker  C, Watson  OJ, Baguelin  M, Winskill  P, Hamlet  A, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science. 2020;369:413–22. DOIPubMedGoogle Scholar
  30. Chandrashekhar  V. Herd immunity? India still has a long way to go, scientists say. Science. 2020;370:513. DOIPubMedGoogle Scholar
  31. Mlcochova  P, Kemp  SA, Dhar  MS, Papa  G, Meng  B, Ferreira  IATM, et al.; Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. 2021;599:114–9. DOIPubMedGoogle Scholar

Main Article

Page created: January 11, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external